Evidence map›Paper›PMID 33079230›Full record

ReviewRheumatology international2021

Gaps between research and recommendations in rheumatoid arthritis.

Ana María Ortiz, Lucía Silva Fernández, Virginia Villaverde, Miguel Ángel Abad, José Ramón Maneiro, Gloria Candelas, Susana Gómez, Mónica Valderrama, María Montoro

Abstract readReview
PubMed Publisher
In one paragraph

Review in Rheumatology international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ana María OrtizRheumatology Service, Hospital Universitario de La Princesa, IIS-IP, Calle Diego de León, 62, 28006, Madrid, Spain. lanult@yahoo.es.
Lucía Silva FernándezRheumatology Service, Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain.ORCID http://orcid.org/0000-0002-5159-6575
Virginia VillaverdeRheumatology Service, Hospital Universitario de Móstoles, Madrid, Spain.ORCID http://orcid.org/0000-0001-8172-3590
Miguel Ángel AbadRheumatology Service, Hospital Virgen del Puerto, Plasencia, Cáceres, Spain.
José Ramón ManeiroRheumatology Service, Complexo Hospitalario Universitario de Pontevedra e O Salnés, Pontevedra, Spain.ORCID http://orcid.org/0000-0003-1052-8709
Gloria CandelasUGC of Rheumatology, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.ORCID http://orcid.org/0000-0001-7759-5127
Susana GómezMedical Department, Pfizer, Madrid, Spain.
Mónica ValderramaMedical Department, Pfizer, Madrid, Spain.
María MontoroMedical Department, Pfizer, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo identify recommendations on the diagnosis and management of rheumatoid arthritis (RA) supported by low recommendation grades, to study the causes of this low grading, and to propose solutions.

methodsA group of six rheumatologists, with extensive experience in the development of systematic reviews, reviewed national and international RA recommendations and practice guidelines. They identified all recommendations with a low level of evidence or recommendation grade (levels equivalent to 4, 5, or grades C or D of the Oxford Levels of Evidence), classified them by areas (diagnosis, follow-up, treatment, others), and analyzed plausible causes of low graduation. A Delphi was used to select 10 recommendations where it was most important to obtain quality evidence to support them. Subsequently, actions were proposed to improve evidence and recommendation grading.

resultsFourteen documents were analyzed, in which 192 recommendations with low evidence/grade of recommendation were identified, most of which were on treatment. The two most frequent causes of this low level are the absence of studies and the discrepancy between the wording of the recommendation and the evidence used. Finally, the proposed solution to the critical recommendations is a list of unanswered research questions and possible designs to answer them.

conclusionsWe propose to design and promote research that truly supports or rectifies clinical practice and, thus, bridges the gap between existing evidence and critical recommendations.

Indexed as

Arthritis, RheumatoidEvidence-Based MedicineHumansPractice Guidelines as TopicRheumatologySystematic Reviews as TopicClinical practice guidelinesLevel of evidenceRecommendationsRheumatoid arthritisSystematic review

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.